| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 147,6 k € | +5.7% | 139,7 k € | -0.8% | 140,8 k € | +53.5% | 91,7 k € | +0.0% | 91,7 k € | +55.6% | 59,0 k € | +5.3% | 56,0 k € | +18.6% | 47,2 k € | -21.4% | 60,1 k € | +14.0% | 52,7 k € | -8.0% | 57,3 k € | +12.2% | 51,1 k € | -44.7% | 92,3 k € | +20.9% | 76,3 k € | -7.6% | 82,6 k € | -19.6% | 102,8 k € | +17.4% | 87,6 k € | +1.4% | 86,4 k € | -42.2% | 149,4 k € | |
| EBITDA | 138,2 k € | +1.4% | 136,2 k € | -2.3% | 139,4 k € | +60.1% | 87,1 k € | -4.7% | 91,4 k € | +56.8% | 58,3 k € | +10.0% | 53,0 k € | +18.6% | 44,7 k € | -24.4% | 59,1 k € | +15.8% | 51,0 k € | -4.6% | 53,5 k € | +75.8% | 30,4 k € | +24.7% | 24,4 k € | +117.1% | 11,2 k € | -55.7% | 25,4 k € | -44.0% | 45,4 k € | -9.6% | 50,2 k € | -21.6% | 64,1 k € | -28.2% | 89,2 k € | |
| Operating profit | 87,5 k € | -0.6% | 88,0 k € | -4.2% | 91,9 k € | +123.3% | 41,1 k € | -30.7% | 59,3 k € | +53.2% | 38,7 k € | +2.5% | 37,8 k € | +62.7% | 23,2 k € | -38.8% | 38,0 k € | +23.9% | 30,6 k € | -10.3% | 34,1 k € | +208.3% | 11,1 k € | -24.5% | 14,7 k € | +1005.0% | 1,3 k € | -89.0% | 12,0 k € | +239.6% | -8,6 k € | -166.0% | -3,2 k € | -123.0% | 14,1 k € | -59.2% | 34,6 k € | |
| Profit/loss | 26,5 k € | +0.2% | 26,4 k € | -50.1% | 53,0 k € | +146.9% | 21,5 k € | -47.1% | 40,6 k € | +139.6% | 16,9 k € | -6.2% | 18,1 k € | +127.4% | 7,9 k € | -55.2% | 17,7 k € | +19.7% | 14,8 k € | -22.1% | 19,0 k € | +640.2% | 2,6 k € | -70.4% | 8,7 k € | +977.8% | -986,1 € | -110.7% | 9,3 k € | +191.4% | -10,1 k € | -75.4% | -5,8 k € | -122.6% | 25,5 k € | -13.0% | 29,3 k € | |
| Equity | 304,8 k € | +9.5% | 278,3 k € | +10.5% | 251,9 k € | +26.6% | 198,9 k € | +12.1% | 177,4 k € | +29.6% | 136,9 k € | +14.1% | 119,9 k € | +17.7% | 101,9 k € | +8.4% | 94,0 k € | +23.2% | 76,2 k € | +24.1% | 61,4 k € | +44.7% | 42,4 k € | -55.9% | 96,3 k € | +9.9% | 87,6 k € | -1.1% | 88,6 k € | +11.7% | 79,4 k € | -11.3% | 89,5 k € | -15.2% | 105,5 k € | +13.4% | 93,0 k € | |
| Total assets | 1,0 M € | +2.1% | 1,0 M € | -6.5% | 1,1 M € | +12.0% | 972,0 k € | -2.3% | 994,8 k € | +60.3% | 620,7 k € | +1.5% | 611,6 k € | +1.7% | 601,3 k € | +4.7% | 574,0 k € | -0.5% | 576,9 k € | -2.1% | 589,4 k € | -0.7% | 593,7 k € | +74.2% | 340,7 k € | -5.4% | 360,1 k € | -2.7% | 370,1 k € | +18.9% | 311,3 k € | -2.6% | 319,6 k € | -16.4% | 382,1 k € | -7.2% | 411,6 k € | |
| Cash | 50,9 k € | -4.9% | 53,6 k € | -26.0% | 72,3 k € | -0.2% | 72,5 k € | +13.8% | 63,7 k € | -1.6% | 64,7 k € | +5.7% | 61,2 k € | -0.8% | 61,7 k € | +26.5% | 48,8 k € | -27.9% | 67,7 k € | -19.8% | 84,3 k € | -6.1% | 89,9 k € | -24.9% | 119,7 k € | -10.0% | 133,0 k € | -7.2% | 143,3 k € | +18.5% | 120,9 k € | +11.6% | 108,3 k € | -13.0% | 124,4 k € | -5.9% | 132,2 k € | |
| Debts | 734,8 k € | -0.6% | 739,6 k € | -11.6% | 836,5 k € | +8.2% | 773,1 k € | -5.4% | 817,3 k € | +68.9% | 483,8 k € | -1.6% | 491,7 k € | -1.5% | 499,4 k € | +4.0% | 480,1 k € | -4.1% | 500,6 k € | -5.2% | 528,0 k € | -4.2% | 551,2 k € | +130.2% | 239,5 k € | -10.4% | 267,3 k € | -3.0% | 275,6 k € | +22.0% | 225,9 k € | -0.1% | 226,3 k € | -17.0% | 272,7 k € | -6.1% | 290,5 k € | |
| Staff | — | — | — | — | — | — | — | 0,5 | 0,5 | 0,5 | 0,5 | 0,5 | 1,3 | 1,4 | 1,4 | 1,4 | 1,4 | 0,9 | 0,4 | |||||||||||||||||||
Private limited company · Aalst · incorporated on 05/08/2003
Private limited company profitable and well capitalised.
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
Apotheek Stuerebaut is a Private limited company incorporated in 2003. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Aalst.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette